A detailed history of Keebeck Wealth Management, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Keebeck Wealth Management, LLC holds 50,000 shares of ARDX stock, worth $260,000. This represents 0.05% of its overall portfolio holdings.

Number of Shares
50,000
Previous 50,000 -0.0%
Holding current value
$260,000
Previous $370,000 7.03%
% of portfolio
0.05%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.22 - $2.85 $61,000 - $142,500
50,000 New
50,000 $142,000
Q2 2022

Aug 15, 2022

SELL
$0.51 - $1.17 $25,500 - $58,500
-50,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$0.86 - $1.7 $34,400 - $68,000
40,000 Added 400.0%
50,000 $55,000
Q3 2021

Nov 16, 2021

SELL
$1.27 - $8.17 $1,270 - $8,170
-1,000 Reduced 9.09%
10,000 $13,000
Q2 2021

Aug 16, 2021

BUY
$6.55 - $8.98 $72,050 - $98,780
11,000 New
11,000 $83,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $804M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Keebeck Wealth Management, LLC Portfolio

Follow Keebeck Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Wealth Management, LLC with notifications on news.